带班班长

苏州东瑞制药有限公司

Chinese pharmaceutical company established on 8 December 1995 in Suzhou, Jiangsu as a wholly Hong Kong, Macao and Taiwan invested enterprise with 131.5 million US dollars of registered capital and Li Qiling as legal representative, and the core company of Dawnrays Pharmaceutical (Holdings), listed on the main board of the Hong Kong Stock Exchange on 11 July 2003. Develops, manufactures and sells cephalosporin antibiotics covering intermediates, active ingredients and powder injections, together with specialty medicines for allergy, the cardiovascular, digestive, urinary and endocrine systems in tablet, capsule and granule form. Was among the first companies in China to obtain drug GMP certification, was named a backbone enterprise of the national Torch programme Wuzhong pharmaceutical industry base in 2001, a Jiangsu high-tech enterprise in 2002 and a national Torch programme key high-tech enterprise in 2003.